Log in to your Inderes Free account to see all free content on this page.
EQL Pharma
52.30 SEK
-2.43 %
Less than 1K followers
EQL
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for EQL Pharma
| Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26 | Q2/26 | Q3/26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 82.8 | 85.3 | 92.2 | 113.3 | 373.5 | 107.2 | 86.4 | 118.9 |
| EBITDA | 15.2 | 14.3 | 14.8 | 23.0 | 67.4 | 20.5 | 8.9 | 24.9 |
| EBIT | 15.2 | 14.3 | 14.8 | 23.0 | 67.4 | 20.5 | 3.6 | 19.5 |
| EBIT-% | 18.4 % | 16.8 % | 16.1 % | 20.3 % | 18.0 % | 19.1 % | 4.2 % | 16.4 % |
| Profit before taxes | 13.1 | 12.1 | 12.7 | 16.5 | 54.4 | 12.4 | -4.2 | 12.3 |
| Net income | 10.4 | 9.6 | 10.1 | 13.1 | 43.1 | 9.8 | -3.4 | 9.8 |
Login required
This content is only available for logged in users